RecruitingRecruiting
Statins and ARBs on Rheumatoid Activity
NCT03770702 · Tanta University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients
About this study
The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Eligibility criteria
Inclusion Criteria:
* Rheumatoid arthritis.
Exclusion Criteria:
* Pregnant or lactating
* Hepatic or renal impairment.
Study design
Enrollment target: 45 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2018-10-01
Estimated completion: 2026-12-01
Last updated: 2018-12-10
Interventions
Drug: Angiotensin receptor blockersDrug: Statins
Primary outcomes
- • Change in disease activity score (6 months)
Sponsor
Sherief Abd-Elsalam · other
Contacts & investigators
ContactSherief Abd-Elsalam, Ph D · contact · sheriefabdelsalam@yahoo.com · 00201147773440
InvestigatorSahar K Hegazy, Prof · principal_investigator, Head of Clinical Pharmacy Department
InvestigatorTarek M Mostafa, Prof · study_director, Prof of Clinical Pharmacy
InvestigatorEmad M Elshebini, MD · study_chair, Rheumatology Dept. - Menoufia University
All locations (1)
Sherief Abd-ElsalamRecruiting
Tanta, Egypt